Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-23 Sale |
2024-01-23 8:37 pm |
Mirati Therapeutics Inc. | MRTX | Sandler Alan B. Chief Medical Officer |
79,865 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-11 Option Award |
2025-04-15 4:19 pm |
N/A 2035-04-11 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Sandler Alan B. Chief Medical Officer |
125,000 | $0 | 125,000 (Direct) |
View |
| 2025-01-21 Option Award |
2025-01-23 6:11 pm |
N/A 2035-01-20 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Sandler Alan B. Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-11-18 Option Award |
2024-11-19 4:05 pm |
N/A 2034-11-17 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Sandler Alan B. Chief Medical Officer |
600,000 | $0 | 600,000 (Direct) |
View |
| 2024-08-05 Option Award |
2024-08-07 5:23 pm |
N/A 2034-08-04 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Sandler Alan B. Director |
40,400 | $0 | 40,400 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-17 4:30 pm |
N/A 2034-06-12 |
Elevation Oncology Inc. | ELEV | Sandler Alan B. Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2024-02-29 Option Award |
2024-03-04 4:40 pm |
N/A 2034-02-28 |
Elevation Oncology Inc. | ELEV | Sandler Alan B. Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 6:01 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Sandler Alan B. Chief Medical Officer |
17,021 | $58.75 | 79,318 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-10 4:19 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Sandler Alan B. Chief Medical Officer |
22,297 | $37 | 62,297 (Direct) |
View |
| 2022-11-07 Option Award |
2022-11-08 6:00 pm |
N/A 2032-11-06 |
Mirati Therapeutics Inc. | MRTX | Sandler Alan B. Chief Medical Officer |
105,000 | $0 | 105,000 (Direct) |
View |
| 2022-06-25 Option Award |
2022-06-27 9:44 pm |
N/A N/A |
Zai Lab Ltd | ZLAB | Sandler Alan B. Head of Global Dev., Oncology |
73,000 | $0 | 73,000 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 4:05 pm |
N/A 2032-04-01 |
Zai Lab Ltd | ZLAB | Sandler Alan B. Head of Global Dev., Oncology |
104,391 | $0 | 137,616 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 4:05 pm |
N/A N/A |
Zai Lab Ltd | ZLAB | Sandler Alan B. Head of Global Dev., Oncology |
1,060 | $0 | 137,616 (Direct) |
View |
| 2021-12-01 Tax Withholding |
2021-12-03 6:29 pm |
N/A N/A |
Zai Lab Ltd | ZLAB | Sandler Alan B. Head of Global Dev., Oncology |
2,075 | $71.23 | 27,925 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 9:44 pm |
N/A 2031-04-01 |
Zai Lab Ltd | ZLAB | Sandler Alan B. Head of Global Dev., Oncology |
33,300 | $0 | 33,300 (Direct) |
View |
Ownership |
2021-01-04 07:34 am |
N/A N/A |
Zai Lab Ltd | ZLAB | Sandler Alan B. Head of Global Dev., Oncology |
0 | $0 | 77,000 (Direct) |
View |